Clostridium butyricum therapy restores the decreased efficacy of immune checkpoint blockade in lung cancer patients receiving proton pump inhibitors

丁酸梭菌 医学 肺癌 癌症 肠道菌群 内科学 免疫疗法 免疫检查点 免疫系统 肿瘤科 胃肠病学 免疫学 生物 细菌 遗传学
作者
Yusuke Tomita,Yoshihiko Goto,Shinya Sakata,Kosuke Imamura,Ayaka Minemura,Kentaro Oka,Atsushi Hayashi,Takayuki Jodai,Kimitaka Akaike,Moriyasu Anai,Shohei Hamada,Shinji Iyama,Koichi Saruwatari,Sho Saeki,Motomichi Takahashi,Tokunori Ikeda,Takuro Sakagami
出处
期刊:OncoImmunology [Landes Bioscience]
卷期号:11 (1): 2081010-2081010 被引量:114
标识
DOI:10.1080/2162402x.2022.2081010
摘要

Oral microbiota is associated with human diseases including cancer. Emerging evidence suggests that proton pump inhibitors (PPIs), which allow the oral microbiome to translocate into the gut, negatively influence the efficacy of immune checkpoint blockade (ICB) in cancer patients. However, currently there is no effective treatment that restores the decreased efficacy. To address this issue, we retrospectively evaluated 118 advanced or recurrent non-small cell lung cancer (NSCLC) patients treated with ICB and analyzed 80 fecal samples of patients with lung cancer by 16S metagenomic sequencing. Clostridium butyricum therapy using C. butyricum MIYAIRI 588 (CBM588), a live biotherapeutic bacterial strain, was shown to improve the ICB efficacy in lung cancer. Thus, we investigated how CBM588 affects the efficacy of ICB and the gut microbiota of lung cancer patients undergoing PPI treatment. We found that PPI treatment significantly decreased the efficacy of ICB in NSCLC patients, however, CBM588 significantly restored the diminished efficacy of ICB and improved survival. In addition, CBM588 prolonged overall survival in patients receiving PPIs and antibiotics together. The fecal analysis revealed that PPI users had higher abundance of harmful oral-related pathobionts and lower abundance of beneficial gut bacteria for immunotherapy. In contrast, patients who received CBM588 had lesser relative abundance of potentially harmful oral-related bacteria in the gut. Our research suggests that manipulating commensal microbiota by CBM588 may improve the therapeutic efficacy of ICB in cancer patients receiving PPIs, highlighting the potential of oral-related microbiota in the gut as a new therapeutic target for cancer immunotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
1秒前
情怀的应助被闪耀的启明星采纳,获得10
1秒前
LYB完成签到 ,获得积分10
1秒前
2秒前
syvshc的应助被00hello00采纳,获得10
2秒前
呆桃完成签到 ,获得积分10
3秒前
王亚娟发布了新的文献求助10
4秒前
kookery完成签到,获得积分10
4秒前
贪玩丑发布了新的文献求助10
4秒前
拼搏惜金完成签到,获得积分10
4秒前
5秒前
刻苦的绿真完成签到 ,获得积分10
5秒前
科研通AI6.2的应助被茉莉花采纳,获得30
5秒前
Gu0F1发布了新的文献求助10
6秒前
wewe发布了新的文献求助10
6秒前
Yx发布了新的文献求助10
6秒前
Gustav_Lebon完成签到,获得积分10
6秒前
6秒前
袁帅完成签到 ,获得积分10
6秒前
7秒前
7秒前
Yifan完成签到,获得积分10
8秒前
yuan完成签到,获得积分10
8秒前
OK给青年才俊的求助进行了留言
8秒前
大个的应助被陈好采纳,获得30
9秒前
9秒前
10秒前
Mistyrain完成签到,获得积分10
11秒前
11秒前
Snowychen完成签到,获得积分10
12秒前
lyb完成签到 ,获得积分10
12秒前
双曲完成签到,获得积分10
12秒前
12秒前
12秒前
空集发布了新的文献求助10
13秒前
13秒前
yan发布了新的文献求助10
13秒前
ning发布了新的文献求助10
13秒前
科研通AI65的应助被不灵0采纳,获得10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264